About: isa:351010806   Sponge Permalink

An Entity of Type : prov:Entity, within Data Space : webisa.webdatacommons.org associated with source dataset(s)

AttributesValues
rdf:type
prov:value
  • Nevertheless, recent data from a phase I clinical trial suggests that administration of neutralizing monoclonal antibodies against IFN?? can ameliorate disease activity [97].The foregoing evidence clearly implicates TNF in the accelerated atherogenesis and other cardiovascular events associated with autoimmune diseases such as rheumatoid arthritis (RA) and SLE. Several TNF antagonists are currentl
prov:wasQuotedFrom
is prov:wasDerivedFrom of
Alternative Linked Data Views: ODE     Raw Data in: CXML | CSV | RDF ( N-Triples N3/Turtle JSON XML ) | OData ( Atom JSON ) | Microdata ( JSON HTML) | JSON-LD    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3217, on Linux (x86_64-pc-linux-gnu), Standard Edition
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2012 OpenLink Software